BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10359144)

  • 1. Establishment of two glioma cell lines from two surgical specimens obtained at different times from the same individual.
    Onda K; Nagai S; Tanaka R; Morii K; Yoshimura JI; Tsumanuma I; Kumanishi T
    J Neurooncol; 1999 Feb; 41(3):247-54. PubMed ID: 10359144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations.
    Zhang S; Endo S; Koga H; Ichikawa T; Feng X; Onda K; Washiyama K; Kumanishi T
    Jpn J Cancer Res; 1996 Sep; 87(9):900-7. PubMed ID: 8878451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y; Yoshimoto T; Sekiya T
    Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines.
    Ishii N; Maier D; Merlo A; Tada M; Sawamura Y; Diserens AC; Van Meir EG
    Brain Pathol; 1999 Jul; 9(3):469-79. PubMed ID: 10416987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and partial characterization of five malignant glioma cell lines.
    Zhang L; Yamane T; Satoh E; Amagasaki K; Kawataki T; Asahara T; Furuya K; Nukui H; Naganuma H
    Neuropathology; 2005 Jun; 25(2):136-43. PubMed ID: 15875906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous deletions of p16INK4A/MTS1 and p15INK4B/MTS2 genes in glioma cells and primary glioma tissues.
    Izumoto S; Arita N; Ohnishi T; Hiraga S; Taki T; Hayakawa T
    Cancer Lett; 1995 Nov; 97(2):241-7. PubMed ID: 7497469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rate of homozygous CDKN2A/p16 deletions in glioma cell lines and in primary tumors.
    Hartmann C; Kluwe L; Lücke M; Westphal M
    Int J Oncol; 1999 Nov; 15(5):975-82. PubMed ID: 10536182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
    Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
    Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas.
    Saxena A; Robertson JT; Ali IU
    Oncogene; 1996 Aug; 13(3):661-4. PubMed ID: 8760309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletions and rearrangements inactivate the p16INK4 gene in human glioma cells.
    Srivenugopal KS; Ali-Osman F
    Oncogene; 1996 May; 12(9):2029-34. PubMed ID: 8649864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins RB; Lassam NJ; Hogg D
    Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of human glioma cell lines with the p16 gene inhibits cell proliferation.
    Hama S; Sadatomo T; Yoshioka H; Kurisu K; Tahara E; Naruse I; Heike Y; Saijo N
    Anticancer Res; 1997; 17(3C):1933-8. PubMed ID: 9216647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
    Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR
    Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and sequencing of the Syrian Golden hamster (Mesocricetus auratus) p16(INK4a) and p15(INK4b) cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells.
    Muscarella P; Knobloch TJ; Ulrich AB; Casto BC; Moniaux N; Wittel UA; Melvin WS; Pour PM; Song H; Gold B; Batra SK; Weghorst CM
    Gene; 2001 Oct; 278(1-2):235-43. PubMed ID: 11707341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
    Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
    Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations associated with glioma progression.
    Kleihues P; Lübbe J; Watanabe K; von Ammon K; Ohgaki H
    Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [p16 tumor suppressor gene alteration in brain tumors].
    Kumanishi T
    No To Shinkei; 1998 Jun; 50(6):511-7. PubMed ID: 9656246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.